enzastaurin has been researched along with Lymphoma, Non-Hodgkin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camargo, JF; Crespo-Solis, E; Eliadis, PE; Forsyth, CJ; Gomez-Almaguer, D; Gutierrez-Aguirre, CH; Hamid, O; Lin, B; Pereira, J; Rivas-Vera, S; Roberson, S; Smith, NV | 1 |
| Hagemeister, FB | 1 |
1 review(s) available for enzastaurin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Maintenance and consolidation strategies in non-Hodgkin's lymphoma: A review of the data.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Everolimus; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lenalidomide; Lymphoma, Non-Hodgkin; Protein-Tyrosine Kinases; Radioimmunotherapy; Randomized Controlled Trials as Topic; Risk Factors; Rituximab; Secondary Prevention; Signal Transduction; Sirolimus; Survival Rate; Thalidomide; Treatment Outcome | 2010 |
1 trial(s) available for enzastaurin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
A multicenter, open-label, noncomparative screening study of enzastaurin in adult patients with non-Hodgkin lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Indoles; Lymphoma, Non-Hodgkin; Male; Middle Aged; Young Adult | 2013 |